What is Appital?
Appital operates as a sophisticated equity capital marketplace, providing the buy-side community with enhanced access to deal flow and execution capabilities within the challenging landscape of illiquid small and mid-cap stocks. Based in London, United Kingdom, the company addresses a critical market need by facilitating greater liquidity and opportunity for investors in less-traded segments of the stock market. Its platform aims to streamline the investment process and broaden market participation.
How much funding has Appital raised?
Appital has raised a total of $5.5M across 2 funding rounds:
Unspecified
$3.5M
Unspecified
$2M
Unspecified (2021): $3.5M with participation from Frontline Ventures
Unspecified (2022): $2M led by Frontline Ventures
Key Investors in Appital
Frontline Ventures
Frontline Ventures is a venture capital firm focused on globally ambitious B2B businesses, with a particular emphasis on early-stage companies and US-to-Europe expansion. They manage significant funds and have a track record of successful exits, indicating a strategic interest in scaling technology platforms.
What's next for Appital?
The recent major strategic investment into Appital, following its substantial total funding of $5.5M, indicates a strong validation of its business model and market potential. This capital is expected to fuel further development of its equity capital marketplace, potentially expanding its reach into new markets or enhancing its technological infrastructure. The company is likely poised for accelerated growth, aiming to solidify its position as a key player in facilitating access to illiquid small and mid-cap stock opportunities.
See full Appital company page
